CATALOGO DEI PRODOTTI DELLA RICERCA

SACERDOTI, David
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.172
AS - Asia 5.908
NA - Nord America 5.246
SA - Sud America 902
AF - Africa 108
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 18.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.136
SG - Singapore 2.825
RU - Federazione Russa 2.769
CN - Cina 1.463
GB - Regno Unito 948
BR - Brasile 713
HK - Hong Kong 574
FR - Francia 567
IE - Irlanda 535
VN - Vietnam 436
KR - Corea 291
UA - Ucraina 277
DE - Germania 269
IT - Italia 245
SE - Svezia 242
FI - Finlandia 144
ID - Indonesia 88
AR - Argentina 75
CA - Canada 54
EC - Ecuador 43
IN - India 38
BD - Bangladesh 37
MX - Messico 36
AT - Austria 34
TR - Turchia 28
ES - Italia 25
JP - Giappone 23
NL - Olanda 23
PL - Polonia 23
TG - Togo 22
ZA - Sudafrica 22
CO - Colombia 21
AU - Australia 19
BE - Belgio 18
BJ - Benin 17
CL - Cile 14
IQ - Iraq 12
PK - Pakistan 12
PY - Paraguay 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
PE - Perù 9
LT - Lituania 8
DZ - Algeria 7
MA - Marocco 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
NP - Nepal 6
RO - Romania 6
AL - Albania 5
JO - Giordania 5
TN - Tunisia 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
IL - Israele 4
KE - Kenya 4
MY - Malesia 4
NO - Norvegia 4
SA - Arabia Saudita 4
CH - Svizzera 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
MD - Moldavia 3
PH - Filippine 3
RS - Serbia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
GT - Guatemala 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
MK - Macedonia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
Totale 18.343
Salva come PNG Salva come JPEG
Città #
Singapore 1.083
Southend 844
Jacksonville 788
Moscow 746
Dallas 574
Hong Kong 568
Chandler 548
Ashburn 546
Dublin 533
Beijing 280
Lawrence 262
Princeton 262
Wilmington 220
Los Angeles 144
Ho Chi Minh City 132
Jinan 121
Redondo Beach 111
Munich 105
Helsinki 98
Buffalo 96
Hanoi 81
Shenyang 81
Ann Arbor 80
Dong Ket 79
São Paulo 65
New York 63
Jakarta 62
Sindelfingen 59
Tianjin 55
Nanjing 52
Ningbo 51
Changsha 50
Santa Clara 50
Haikou 41
Hebei 41
Columbus 38
Hangzhou 38
San Francisco 38
Verona 37
Milan 35
London 34
Seattle 34
Zhengzhou 34
Guangzhou 32
Houston 32
Taizhou 32
Fairfield 30
Nanchang 30
Nuremberg 29
Brooklyn 27
Taiyuan 25
Norwalk 24
Redwood City 23
Turku 23
Boston 22
Lomé 22
Tokyo 22
Warsaw 22
Falkenstein 21
Lanzhou 21
Washington 21
The Dalles 19
Brussels 18
Council Bluffs 18
Rio de Janeiro 18
Toronto 18
Cotonou 17
Chicago 16
Guayaquil 16
Mexico City 15
Redmond 15
Stockholm 15
Vienna 15
Brasília 14
Da Nang 14
Jiaxing 14
Lappeenranta 14
San Diego 14
Belo Horizonte 13
Curitiba 13
Montreal 13
Woodbridge 13
Fuzhou 12
Johannesburg 12
Phoenix 12
Rome 12
Romola 12
Atlanta 11
Charlotte 11
Meda 11
Porto Alegre 11
Amsterdam 10
Biên Hòa 10
Denver 10
Frankfurt am Main 10
Haiphong 10
Hải Dương 10
Ankara 9
Boardman 9
Bonndorf 9
Totale 10.230
Salva come PNG Salva come JPEG
Nome #
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 222
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 169
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 163
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 163
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 140
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 132
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 119
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 119
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 116
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 114
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 110
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 108
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 105
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 104
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 104
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 101
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 97
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 97
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 96
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 96
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 95
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 94
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 94
Subclinical and clinical atherosclerosis in Non-alcoholic Fatty Liver Disease is associated with the presence of hypertension 92
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 92
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 91
Alteration in endothelial function in cirrhosis 91
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 90
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 88
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 86
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 86
Alterazioni epatiche in corso di scompenso cardiaco 85
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 84
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 84
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 83
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 83
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 82
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 82
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia 81
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 81
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 81
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients 80
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 80
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 80
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 79
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 77
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 77
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 77
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 77
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 77
Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis 76
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 76
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 76
Left ventricular diastolic function in liver cirrhosis 76
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 75
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 75
A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease 74
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 74
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study 73
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study 73
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 73
Vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler. 73
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 73
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 73
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 72
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 71
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal va¬rices 71
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 71
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 70
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 70
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 70
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 70
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 70
Renal function in congestive heart failure. 70
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis 70
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 70
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 69
Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis 69
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 69
Drugs in the prevention of rebleeding in cirrhosis 69
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 69
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 69
Effetti dell'Iloprost sull'emodinamica renale, sul metabolismo intrarenale del sodio e sul sistema renina-angiotensina-aldosterone. 68
Interobserver and interequipment variability of hepatic, splenic, and renal arterial Doppler resistance indices in normal subjects and patients with cirhosis. J Hepatol 1997; 27: 986-992 (IF=4.974) 68
Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients 68
intrahepatic arterioportal fistulas in cirrhosis: usefulness of echo-Doppler as screening procedure 68
Renal effects of nadolol in cirrhosis 68
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 68
Platelets in Non-alcoholic Fatty Liver Disease 68
Efficacia di un trattamento diuretico organizzato per "steps" nella terapia dell'ascite in corso di cirrosi epatica. 67
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 67
The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations 67
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment 67
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 67
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 66
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 66
Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis. 66
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 66
La profilassi primaria dell'emorragia da rottura di varici esofagee 66
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 66
Totale 8.510
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.914
article - articoli 66.040
book - libri 824
conference - conferenze 13.027
curatela - curatele 0
other - altro 453
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.570
Totale 167.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.041 0 0 0 0 264 295 23 9 12 8 332 98
2021/20221.598 104 209 11 23 111 21 54 116 108 116 238 487
2022/20232.483 283 156 347 236 379 701 15 101 162 10 49 44
2023/20241.224 52 86 86 113 70 198 129 77 2 63 251 97
2024/20254.564 298 280 183 803 163 51 110 480 523 244 361 1.068
2025/20266.289 1.149 687 692 1.848 1.913 0 0 0 0 0 0 0
Totale 18.795